Vimarsana
Biggest News Aggregation in the World

Page 14 - Presentation Details News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Details Today - Breaking & Trending Today

Rigel Announces Poster Presentation at the Upcoming 2023 American Society of Clinical Oncology Annual Meeting - Vimarsana News

Rigel Announces Poster Presentation at the Upcoming 2023 American Society of Clinical Oncology Annual Meeting

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced an upcoming poster presentation highlighting the Company's IRAK1/4 program at the...

Gate Neurosciences to Highlight New Biomarker Data & Host R&D Day at 2023 ASCP Annual Meeting - Vimarsana News

Gate Neurosciences to Highlight New Biomarker Data & Host R&D Day at 2023 ASCP Annual Meeting

INDIANAPOLIS--(BUSINESS WIRE)--May 24, 2023--

Source: wsiltv.com
4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting - Vimarsana News

4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting

Interim data to be presented in an oral presentation by Dr. Jennifer L. Taylor-Cousar, MD, MSCS at the 2023 ECFS Annual Meeting in Vienna, Austria on Thursday, June 8, 2023 at 5:00 p.m. CET Company to... | May 24, 2023

Monday.com Announces First Quarter 2023 Results - Vimarsana News

Monday.com Announces First Quarter 2023 Results

First quarter revenue of $162.3 million grew 50% year over year Number of customers with more than $50k ARR grew 75% year over year Achieved record quarterly revenue and free cash flow Announced... | May 15, 2023

Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting - Vimarsana News

Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting

Updated iptacopan data confirm hemolysis control in paroxysmal nocturnal hemoglobinuria patients from Phase III APPLY-PNH and APPOINT-PNH studies Head-to-head data from Phase III... | May 11, 2023